T1	PROC 46 55	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	PROC 62 73	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 102 109	fármaco
#3	AnnotatorNotes T3	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T4	PROC 143 154	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	CHEM 110 120	Remdesivir
#5	AnnotatorNotes T5	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
T6	DISO 161 180	infección SARS-CoV2
T7	PROC 229 238	Protocolo
#6	AnnotatorNotes T7	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T8	PROC 243 254	tratamiento
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	PROC 309 320	tratamiento
#8	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 327 346	infección SARS-CoV2
T11	CHEM 276 286	Remdesivir
#9	AnnotatorNotes T11	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
T12	DISO 377 411	Enfermedad por el Coronavirus 2019
#10	AnnotatorNotes T12	C5203670; COVID19 (disease); Disease or Syndrome
T13	PROC 620 656	consentimiento informado por escrito
#11	AnnotatorNotes T13	C0811741; Obtain informed written consent; Health Care Activity
T14	PROC 961 974	Hospitalizado
#12	AnnotatorNotes T14	C0019993; Hospitalization; Health Care Activity
T15	CHEM 126 133	GS-5734
#13	AnnotatorNotes T15	C4279131; GS-5734; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T16	DISO 413 421	COVID-19
#14	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	CHEM 288 291	RDV
T18	DISO 1076 1084	COVID-19
#15	AnnotatorNotes T18	C5203670; COVID19 (disease); Disease or Syndrome
T19	DISO 1051 1059	síndrome
#16	AnnotatorNotes T19	C0039082; Syndrome; Disease or Syndrome
T20	PROC 722 746	consentimiento informado
#17	AnnotatorNotes T20	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T21	PROC 1115 1144	ventilación mecánica invasiva
#18	AnnotatorNotes T21	C1868981; Invasive mechanical ventilation; Therapeutic or Preventive Procedure
T22	CHEM 122 125	RDV
T23	PROC 1180 1190	intubación
#19	AnnotatorNotes T23	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T24	PROC 1193 1205	traqueotomía
#20	AnnotatorNotes T24	C0040591; Tracheotomy procedure; Therapeutic or Preventive Procedure
T25	PROC 1241 1279	tasa estimada de filtración glomerular
#21	AnnotatorNotes T25	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T26	PROC 1545 1549	eGRF
#22	AnnotatorNotes T26	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T27	DISO 1447 1466	fallo multiorgánico
#23	AnnotatorNotes T27	C0026766; Multiple Organ Failure; Pathologic Function
T28	DISO 1532 1543	Fallo renal
#24	AnnotatorNotes T28	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T29	PROC 1576 1611	Veno-Hemofiltración venosa continua
T30	ANAT 1596 1602	venosa
#25	AnnotatorNotes T30	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T31	PROC 1004 1007	PCR
#26	AnnotatorNotes T31	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T32	PROC 1089 1092	PCR
#27	AnnotatorNotes T32	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T33	ANAT 1218 1223	renal
#28	AnnotatorNotes T33	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T34	PROC 1327 1330	ALT
#29	AnnotatorNotes T34	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T35	ANAT 1519 1528	sanguínea
#30	AnnotatorNotes T35	C0005767; Blood; Body Substance
T36	ANAT 1538 1543	renal
#31	AnnotatorNotes T36	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T37	PROC 1565 1573	diálisis
#32	AnnotatorNotes T37	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T38	CHEM 292 299	GS-5734
#33	AnnotatorNotes T38	C4279131; GS-5734; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T39	CHEM 1487 1493	presor
#34	AnnotatorNotes T39	C0042397; Vasoconstrictor Agents; Pharmacologic Substance
T40	Date 13 17	2020
T41	LIVB 190 205	sujetos adultos
#35	AnnotatorNotes T41	C0681850; Study Subject; Group + C0001675; Adult; Age Group
T43	LIVB 395 406	Coronavirus
#36	AnnotatorNotes T43	C5203676; SARS-CoV-2; Virus
T44	LIVB 453 460	sujetos
#37	AnnotatorNotes T44	C0681850; Study Subject; Group
T45	LIVB 681 700	representante legal
#38	AnnotatorNotes T45	C4288823; Legal Representative for the Study; Human
T47	LIVB 898 910	investigador
#39	AnnotatorNotes T47	C0035173; Research Personnel; Professional or Occupational Group
T48	Age 929 937	≥18 años
T49	Age 948 957	≥ 18 años
T50	PHYS 1210 1223	Función renal
#40	AnnotatorNotes T50	C0232804; Renal function; Organ or Tissue Function
T52	PHYS 1511 1528	presión sanguínea
#41	AnnotatorNotes T52	C0005823; Blood Pressure; Organism Function
T54	PHYS 1615 1623	Embarazo
#42	AnnotatorNotes T54	C0032961; Pregnancy; Organism Function
T42	LIVB 337 346	SARS-CoV2
#43	AnnotatorNotes T42	C5203676; SARS-CoV-2; Virus
T46	LIVB 912 925	participantes
#44	AnnotatorNotes T46	C4554048; Study Participant; Population Group
T51	LIVB 979 988	SARS-CoV2
#45	AnnotatorNotes T51	C5203676; SARS-CoV-2; Virus
T53	LIVB 171 180	SARS-CoV2
#46	AnnotatorNotes T53	C5203676; SARS-CoV-2; Virus
T55	PHYS 1258 1279	filtración glomerular
#47	AnnotatorNotes T55	C0232809; Glomerular filtration; Organ or Tissue Function
T56	ANAT 1269 1279	glomerular
#48	AnnotatorNotes T56	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Population_data T41 Age
#49	AnnotatorNotes T22	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
#50	AnnotatorNotes T17	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
#51	AnnotatorNotes T29	C0472684; Continuous venovenous hemofiltration; Therapeutic or Preventive Procedure 
#52	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
#53	AnnotatorNotes T10	C5203670; COVID19 (disease); Disease or Syndrome
R1	Location_of Arg1:T35 Arg2:T52	
R2	Location_of Arg1:T30 Arg2:T29	
R3	Location_of Arg1:T36 Arg2:T28	
T57	Result_or_Value 1550 1562	< 30 mL/min.
R4	Has_Result_or_Value Arg1:T26 Arg2:T57	
R6	Used_for Arg1:T5 Arg2:T2	
R7	Used_for Arg1:T22 Arg2:T2	
R8	Used_for Arg1:T15 Arg2:T2	
R9	Used_for Arg1:T5 Arg2:T4	
R10	Used_for Arg1:T22 Arg2:T4	
R11	Used_for Arg1:T15 Arg2:T4	
R12	Causes Arg1:T53 Arg2:T6	
R13	Experiences Arg1:T41 Arg2:T2	
R14	Experiences Arg1:T41 Arg2:T3	
R15	Experiences Arg1:T41 Arg2:T5	
R16	Experiences Arg1:T41 Arg2:T22	
R17	Experiences Arg1:T41 Arg2:T15	
R18	Experiences Arg1:T41 Arg2:T4	
R19	Experiences Arg1:T41 Arg2:T6	
R20	Causes Arg1:T42 Arg2:T10	
R21	Causes Arg1:T43 Arg2:T12	
R22	Causes Arg1:T43 Arg2:T16	
R23	Used_for Arg1:T11 Arg2:T8	
R24	Used_for Arg1:T17 Arg2:T8	
R25	Used_for Arg1:T38 Arg2:T8	
R26	Used_for Arg1:T11 Arg2:T9	
R27	Used_for Arg1:T17 Arg2:T9	
R28	Used_for Arg1:T38 Arg2:T9	
T58	Observation 467 518	cumplir todos los siguientes criterios de inclusión
#54	AnnotatorNotes T58	C4329786; Eligibility Criteria Met By Subject; Finding
T59	Observation 528 559	elegibles para la participación
#55	AnnotatorNotes T59	C1302261; Patient eligible for clinical trial; Finding
R29	Before Arg1:T58 Arg2:T59	
R30	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T59	
T60	Observation 580 591	Disposición
#56	AnnotatorNotes T60	C0600109; Willing; Finding (?)
T61	Observation 594 603	capacidad
#57	AnnotatorNotes T61	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R31	Overlap Arg1:T61 Arg2:T13	
R32	Overlap Arg1:T60 Arg2:T13	
T62	CONC 750 759	inclusión
#58	AnnotatorNotes T62	C1512693; Inclusion; Qualitative Concept
R33	Has_Age Arg1:T46 Arg2:T48	
R34	Before Arg1:T13 Arg2:T62	
R35	Before Arg1:T20 Arg2:T62	
R36	Overlap Arg1:T31 Arg2:T51	
R37	Overlap Arg1:T14 Arg2:T51	
T63	Observation 1010 1046	contacto conocido de caso confirmado
#59	AnnotatorNotes T63	C5419476; Household Contact with SARS-CoV-2 Positive Individual; Finding (?)
R38	Before Arg1:T63 Arg2:T19	
R39	Before Arg1:T63 Arg2:T18	
R40	Before Arg1:T63 Arg2:T32	
T64	Quantifier_or_Qualifier 1093 1102	pendiente
#60	AnnotatorNotes T64	C1611271; Pending - status; Temporal Concept
R41	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T64	
T65	Route 1163 1179	vía endotraqueal
#61	AnnotatorNotes T65	C0599554; endotracheal; Spatial Concept
R42	Before Arg1:T23 Arg2:T21	
R43	Before Arg1:T24 Arg2:T21	
R44	Has_Route_or_Mode Arg1:T21 Arg2:T65	
R45	Location_of Arg1:T33 Arg2:T50	
T66	Observation 1210 1232	Función renal adecuada
#62	AnnotatorNotes T66	C0232805; Normal renal function; Finding
R46	Location_of Arg1:T33 Arg2:T66	
R50	Location_of Arg1:T56 Arg2:T55	
R51	Location_of Arg1:T56 Arg2:T25	
T67	Result_or_Value 1280 1291	≥ 30 ml/min
R53	Has_Result_or_Value Arg1:T25 Arg2:T67	
T68	Result_or_Value 1331 1372	≤ 5 x límite superior de normalidad (LSN)
R54	Has_Result_or_Value Arg1:T34 Arg2:T68	
T69	Observation 1499 1528	mantener la presión sanguínea
#63	AnnotatorNotes T69	C4028081; patient goals - maintain normal blood pressure; Finding
R58	Location_of Arg1:T35 Arg2:T69	
T70	Quantifier_or_Qualifier 823 834	de urgencia
#64	AnnotatorNotes T70	C0439609; Urgent; Qualitative Concept
R59	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T70	
A2	Experiencer T41 Patient
A3	Experiencer T44 Patient
A4	Experiencer T45 Other
A5	Experiencer T47 Other
A6	Experiencer T46 Patient
A7	Status T32 Future
